跳至主要内容
临床试验/EUCTR2019-003179-20-NL
EUCTR2019-003179-20-NL进行中(未招募)1 期

‘A pilot study to assess the safety and feasibility of fluorescent sentinel lymph node identification in colon carcinoma using Indocyanine green’ - FLUOR–ICG–SLN(pilot)

Meander Medical Centre0 个研究点目标入组 10 人开始时间: 2020年3月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Oral and written informed consent (IC)
  • - Aged 18 years and older
  • - Pathologically confirmed and/or suspected colon carcinoma
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 5
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • - Distant metastases
  • - Suspicion of T3-T4 disease based on pre-operative assessment.
  • - Metastatic or T4 disease discovered during intraoperative staging
  • - A tumour too large to pass endoscopically
  • - Pregnant patients
  • - Known allergy to any of the compound used for SLN identification (ICG, Iodine)
  • - Suspected or proven lymph node metastasis
  • - Previous colon surgery
  • - Contra-indication for robotic surgery
  • - Ink marking close to the tumour

研究者

发起方
Meander Medical Centre

相似试验

Identification of the sentinel lymph node (SLN) in... | 临床试验